LOTUSEYE
Invest Now
Lotus Eye Hospital and Institute Share Price
₹65.96 +1.54 (2.39%)
17 Nov, 2024 17:10
Start SIP in LOTUSEYE
Start SIPPerformance
- Low
- ₹63
- High
- ₹67
- 52 Week Low
- ₹49
- 52 Week High
- ₹111
- Open Price₹66
- Previous Close₹64
- Volume19,033
Investment Returns
- Over 1 Month -9.74%
- Over 3 Month -8.81%
- Over 6 Month + 7.95%
- Over 1 Year -34.53%
Smart Investing Starts Here Start SIP with Lotus Eye Hospital and Institute for Steady Growth!
Lotus Eye Hospital and Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 97.5
- PEG Ratio
- -1.5
- Market Cap Cr
- 137
- P/B Ratio
- 2.3
- Average True Range
- 3.66
- EPS
- 0.69
- Dividend Yield
- 0
- MACD Signal
- -1.77
- RSI
- 40.75
- MFI
- 42.24
Lotus Eye Hospital and Institute Financials
Lotus Eye Hospital and Institute Technicals
EMA & SMA
Current Price
₹65.96
+
1.54
(2.39%)
- Bullish Moving Average 1
- Bearish Moving Average 15
- 20 Day
- ₹68.42
- 50 Day
- ₹70.58
- 100 Day
- ₹70.34
- 200 Day
- ₹70.61
Resistance and Support
65.4
- R3 71.31
- R2 69.15
- R1 67.56
- S1 63.81
- S2 61.65
- S3 60.06
Lotus Eye Hospital and Institute Corporate Actions - Bonus, Splits, Dividends
Lotus Eye Hospital and Institute F&O
About Lotus Eye Hospital and Institute
- NSE Symbol
- LOTUSEYE
- BSE Symbol
- 532998
- Managing Director
- Ms. Sangeetha Sundaramoorthy
- ISIN
- INE947I01017
Similar Stocks to Lotus Eye Hospital and Institute
Lotus Eye Hospital and Institute FAQs
Lotus Eye Hospital and Institute share price is ₹65 As on 17 November, 2024 | 16:56
The Market Cap of Lotus Eye Hospital and Institute is ₹137.2 Cr As on 17 November, 2024 | 16:56
The P/E ratio of Lotus Eye Hospital and Institute is 97.5 As on 17 November, 2024 | 16:56
The PB ratio of Lotus Eye Hospital and Institute is 2.3 As on 17 November, 2024 | 16:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.